Literature DB >> 7821796

Mutational analysis of the proteolytic cleavage site of glycoprotein B (gB) of Marek's disease virus.

S Yoshida1, L F Lee, N Yanagida, K Nazerian.   

Abstract

The Marek's disease virus (MDV) glycoprotein B (gB) precursor, gp100, is proteolytically cleaved into two disulfide-linked subunits, gp60 and gp49. In the gB homologs of most other herpesviruses, a tetrapeptide, Arg-Xaa-Arg-Arg, is immediately upstream from the predicted cleavage site. We have investigated the specificity of the proteolytic cleavage in gp100 by introducing mutations within its predicted cleavage site (Arg-Leu-Arg-Arg) and expressed these mutants in recombinant fowlpox virus (FPV). The results show that all three Arg residues at the predicted cleavage site play an important role in the specific proteolytic cleavage of gp100. Furthermore, we demonstrated that the cleavage of gp100 is not necessary for transport of gB to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821796     DOI: 10.1016/0378-1119(94)90442-1

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Disulfide bonds of herpes simplex virus type 2 glycoprotein gB.

Authors:  N Norais; D Tang; S Kaur; S H Chamberlain; F R Masiarz; R L Burke; F Marcus
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism.

Authors:  S Yoshida; A Fujisawa; Y Tsuzaki; S Saitoh
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.

Authors:  Xiaojia Wang; Xiaojing Chi; Ming Wang
Journal:  Virol J       Date:  2011-04-25       Impact factor: 4.099

4.  Interaction domain of glycoproteins gB and gH of Marek's disease virus and identification of an antiviral peptide with dual functions.

Authors:  Xiao-Jing Chi; Yi-Xin Lu; Peng Zhao; Chuan-Gen Li; Xiao-Jia Wang; Ming Wang
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.